News
Posted
All
| 2020 | 2019 | 2018 | 2017
RESEARCH UPDATE: ON THE CLINICAL FRONT Genetic Variants May Partially Explain Response to Tomato Juice Intake in Men with Prostate Cancer Tomato product and lycopene intakes are associated with reduced prostate cancer risk... Read More
POSTED: 02/19/2020SOURCE: DCP News
Preventing the Progression of Low-Risk Localized Prostate Cancers: A New Frontier
In the path toward understanding the development and ultimate prevention of prostate cancer, researchers are studying how to keep low-grade, early stage prostate cancer being monitored on Active Surveillance from progressing... Read More
POSTED: 01/17/2020SOURCE: Cancer Prevention Science Blog
Division of Cancer Prevention New Grantees with Acting DCP Division Director Dr. Debbie Winn (first row center). In November 2019, the NCI Division of Cancer Prevention (DCP) for the first time held a New Grantee Workshop... Read More
POSTED: 01/14/2020SOURCE: DCP News
Taking Advantage of the Transportation Processes from Inside to Outside the Cell to Detect Cancer
As cancer researchers delve into the many molecular processes that guide cell life within the body, NCI is looking for ways to characterize and measure different substances in this process, with an eye to identifying who has... Read More
POSTED: 12/11/2019SOURCE: Cancer Prevention Science Blog
RESEARCH UPDATE: ON THE CLINICAL FRONT Selectively Inhibitory Effects of Green Tea Polyphenols on Microbial Metabolism The bioavailability of green tea polyphenols (GTP) is limited and unabsorbed GTP can have bi-... Read More
POSTED: 10/23/2019SOURCE: DCP News
TMIST Ramps Up to Illuminate Breast Cancer Screening
TMIST (Tomosynthesis Mammographic Imaging Screening Trial), the large NCI screening study to learn about the best ways to find breast cancer in women who have no symptoms, is ramping up with 16,505 participants enrolled to... Read More
POSTED: 10/17/2019SOURCE: Cancer Prevention Science Blog
Study Quantifies Impact of NCI-sponsored Trials on Clinical Cancer Care
A new study shows that nearly half of phase 3 cancer clinical trials carried out by the National Cancer Institute (NCI)-sponsored SWOG Cancer Research Network, one of five groups in NCI’s National Clinical Trials Network (... Read More
POSTED: 09/18/2019SOURCE: NCI Press Release
Michigan’s Philip Stella receives NCORP 2019 Harry Hynes Award: Conversation with the Cancer Letter
Philip J. Stella, the principal investigator of the Michigan Cancer Research Consortium NCI Community Oncology Research Program site in Ann Arbor, won the 2019 Harry Hynes Award. The award is given annually to NCORP PIs... Read More
POSTED: 09/13/2019SOURCE: The Cancer Letter
NCI Annual Plan & Budget Proposal for Fiscal Year 2021
The year 2021 will mark the 50th anniversary of the National Cancer Act of 1971, the landmark legislation that intensified support for cancer research in the United States. The investment sparked a biomedical revolution... Read More
POSTED: 09/05/2019SOURCE: NCI Director’s Message
The National Cancer Institute (NCI) has awarded 53 grants to researchers in the NCI Community Oncology Research Program (NCORP) to conduct multi-site cancer clinical trials and cancer care delivery studies in their... Read More
POSTED: 08/19/2019SOURCE: DCP News
Study Suggests Reviewing Lung Cancer Screening Criteria for African Americans
Clinical recommendations on who should be screened for lung cancer are based largely on how long a person smoked and the number of cigarettes they smoked. But current recommendations may need to be reviewed when it comes to... Read More
POSTED: 07/31/2019SOURCE: NCI Cancer Currents Blog
RESEARCH UPDATE: ON THE CLINICAL FRONT Vitamin D Supplements and Prevention of Cancer: the Vitamin D and Omega-3 Trial (VITAL) Observational studies suggest that lower vitamin D levels are associated with a higher cancer... Read More
POSTED: 07/25/2019SOURCE: DCP News
Why I choose to play a dual role in TMIST
By Worta McCaskill-Stevens As a physician-scientist, I have spent my career advancing research in women’s health. I was a part of the planning effort to design and launch TMIST—the Tomosynthesis Mammographic Imaging... Read More
POSTED: 05/24/2019SOURCE: The Cancer Letter
A new video from the National Cancer Institute (NCI) highlights the research efforts of the NCI Community Oncology Research Program (NCORP) in implementing cancer clinical trials and other research studies across the country... Read More
POSTED: 05/16/2019SOURCE: DCP News
Prostate Cancer Prevention and Finasteride: A Conversation with NCI’s Dr. Howard Parnes
In 2003, results from the Prostate Cancer Prevention Trial (PCPT)—an NCI-funded randomized clinical trial with nearly 19,000 participants—showed that men aged 55 and older who used the drug finasteride daily for 7 years had... Read More
POSTED: 05/13/2019SOURCE: NCI Cancer Currents Blog
RESEARCH UPDATE: ON THE CLINICAL FRONT Caffeinated Coffee and Tea and the Risk of Non-Melanoma Skin Cancer Among Chinese Coffee and tea are the most widely consumed beverages in the world and epidemiological evidence... Read More
POSTED: 04/29/2019SOURCE: DCP News
Could a Vaccine Prevent Colorectal Cancer in People with Lynch Syndrome?
Researchers have taken the first steps toward developing a vaccine to prevent cancer in people with Lynch syndrome, an inherited condition that elevates a person’s risk of colorectal, endometrial, and other types of cancer.... Read More
POSTED: 04/19/2019SOURCE: NCI Cancer Currents Blog
TMIST PI Pisano: “Are we further reducing breast cancer mortality the more intensively we screen?”
The Tomosynthesis Mammographic Imaging Screening Trial, a massive randomized trial of early detection, is asking an important question: Is digital breast tomosynthesis better than digital mammography in reducing development... Read More
POSTED: 03/19/2019SOURCE: The Cancer Letter
NCI participated in the American Association for Cancer Research (AACR) Annual Meeting, held March 29–April 3, 2019, at Georgia World Congress Center in Atlanta, GA, including presenting the following research results from... Read More
POSTED: 03/15/2019SOURCE: DCP News
At 12 NCI Community Oncology Research Program (NCORP) sites across the United States, a new kind of study will soon be opening for patients with advanced malignancies being treated with molecularly targeted therapies. The... Read More
POSTED: 03/01/2019SOURCE: DCP News
After Lung Cancer Screening, Follow-Up Procedures May Be Riskier than Thought
Being screened for lung cancer can lead to follow-up diagnostic procedures, including invasive ones. The risk of complications from those invasive procedures may be higher than previously thought, a new study suggests. By... Read More
POSTED: 02/08/2019SOURCE: NCI Cancer Currents Blog
RESEARCH UPDATE: ON THE CLINICAL FRONT Circulating Bile Acids in Response to a Whole vs Refined Grain Dietary Pattern in Healthy Adults Little is known about circulating plasma bile acid concentrations and their capacity... Read More
POSTED: 01/24/2019SOURCE: DCP News
FHP Health Center in Guam was approved in January as the newest affiliate of the National Cancer Institute Community Oncology Research Program (NCORP) to bring cancer clinical trials and cancer care delivery studies to... Read More
POSTED: 01/24/2019SOURCE: DCP News
Managing Cancer Pain: Are Better Approaches on the Horizon?
Pain is a common and much-feared symptom among people being treated for cancer and long-term survivors. Cancer pain can be caused by the disease itself, its treatments, or a combination of the two. It may be short-lived or... Read More
POSTED: 01/23/2019SOURCE: NCI Cancer Currents Blog
The Final Verdict on Finasteride
Finasteride, a generic hormone-blocking drug, was found to reduce the risk of prostate cancer by 25 percent in the landmark Prostate Cancer Prevention Trial (PCPT). Long- term data, published today in the New England Journal... Read More
POSTED: 01/23/2019SOURCE: SWOG News